Pharma Sector

Investors with very high risk appetite and want to invest for 5 to 7 years to diversify their portfolio in healthcare companies stocks should invest in DSP Nifty Healthcare ETF.

GLS has seen a 52% increase in its share price over the past three months, reaching a 52-week high of Rs 595

The company announced plans to consider a fund-raise in an upcoming board meeting scheduled for July 11.

According to Lupin's annual report for 2022, its API arm contributed approximately 6 % to the company's total revenue

LordsMed's goal of facilitating early-stage healthcare intervention and generating Rs75 crore in revenue in six months includes expanding the distribution network.

Dr Reddy’s rituximab biosimilar has already been approved for marketing in India and over 25 emerging markets.

By February 15, the company will invest upto Rs175 crore by subscribing to shares representing a 39.4% stake in the startup.

On Thursday, Ajanta Pharma's promoter entities sold 4.3 percent of their shares for Rs 637 crore.

This is the first product approval from Jarod Facility which was inspected in Dec 2022.

On consolidated basis, Ami Organics reported 9% rise in net profit to Rs 19.04 crore on 20.2% increase in revenue from operation to Rs 146.99 crore in Q2 FY23 over Q2 FY22.